NCT05805683 Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
| NCT ID | NCT05805683 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Calcitonin |
| Study Type | INTERVENTIONAL |
| Enrollment | 126 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2027-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 126 participants in total. It began in 2023-05-01 with a primary completion date of 2027-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective randomized double blinded study will be conducted to evaluate the effect of early pharmacologic intervention with calcitonin on the incidence or the severity of neuropathic pain after spinal cord injury
Eligibility Criteria
Inclusion Criteria: * Patients aged ≥18 years, with spinal cord injury at any level and any degree of completeness in the early stage of trauma. Exclusion Criteria: * Intake of anticonvulsants medications. * Evidence of neuropathic pain. * Evidence of previous allergic reaction to calcitonin. * Patients with renal, hepatic and cardiac dysfunction or neurological disorders . * brain damage or major trauma to extremities or abdomen.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05805683 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Calcitonin. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05805683 currently recruiting?
Yes, NCT05805683 is actively recruiting participants. Contact the research team at osamarehab@med.tanta.edu.eg for enrollment information.
Where is the NCT05805683 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT05805683 clinical trial?
NCT05805683 is sponsored by Tanta University. The trial plans to enroll 126 participants.